{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:17:01Z","timestamp":1792034221290,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","criticalcare.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ccc.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T12:05:56Z","timestamp":1694088356000},"page":"73-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery"],"prefix":"10.1016","volume":"40","author":[{"given":"Orlando R.","family":"Suero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangseon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Wieruszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasis","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ccc.2023.06.002_bib1","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s00134-014-3525-z","article-title":"Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine","volume":"40","author":"Cecconi","year":"2014","journal-title":"Intensive Care Med"},{"issue":"18","key":"10.1016\/j.ccc.2023.06.002_bib2","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.06.002_bib3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccc.2023.06.002_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ejcts.2003.11.032","article-title":"Risk factors and outcomes for 'vasoplegia syndrome' following cardiac transplantation","volume":"25","author":"Byrne","year":"2004","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"6","key":"10.1016\/j.ccc.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: a meta-analysis","volume":"28","author":"Dayan","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"Omar","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ccc.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jclinane.2017.04.017","article-title":"Vasoplegic syndrome: an update on perioperative considerations","volume":"40","author":"Liu","year":"2017","journal-title":"J\u00a0Clin Anesth"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib10","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.athoracsur.2011.04.020","article-title":"Transfusion increases the risk for vasoplegia after cardiac operations","volume":"92","author":"Alfirevic","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/ALN.0000000000002298","article-title":"Defining an intraoperative hypotension threshold in association with stroke in cardiac surgery","volume":"129","author":"Sun","year":"2018","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \"norepinephrine equivalent\" score in intensive care as a marker of shock severity","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib14","doi-asserted-by":"crossref","first-page":"E2022129","DOI":"10.57905\/josh\/e2022129","article-title":"Profound Vasoplegia after coronary artery bypass grafting","volume":"1","author":"Chatterjee","year":"2022","journal-title":"Journal of Shock and Hemodynamics"},{"issue":"8","key":"10.1016\/j.ccc.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMra002709","article-title":"The pathogenesis of vasodilatory shock","volume":"345","author":"Landry","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"issue":"2 Pt 2","key":"10.1016\/j.ccc.2023.06.002_bib17","first-page":"H491","article-title":"Vasopressin modulates K(+)-channel activities of cultured smooth muscle cells from porcine coronary artery","volume":"263","author":"Wakatsuki","year":"1992","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00134-008-1279-1","article-title":"The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study","volume":"35","author":"Jochberger","year":"2009","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.06.002_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"VASST Investigators. Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"VANISH Investigators. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.ccc.2023.06.002_bib21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ccc.2023.06.002_bib22","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ejcts.2006.02.032","article-title":"Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients","volume":"29","author":"Jeon","year":"2006","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-018-1995-z","article-title":"Angiotensin in critical care","volume":"22","author":"Hall","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"ATHOS-3 investigators. Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II Is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a post-hoc analysis of angiotensin ii for the treatment of high-output shock (ATHOS-3) study","volume":"35","author":"Klijian","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ccc.2023.06.002_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.xjtc.2020.08.007","article-title":"Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair","volume":"4","author":"Chatterjee","year":"2020","journal-title":"JTCVS Tech"},{"issue":"11","key":"10.1016\/j.ccc.2023.06.002_bib27","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic human angiotensin II for postcardiopulmonary bypass vasoplegic shock","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib28","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: a multicenter study of postmarketing Use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ccc.2023.06.002_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jtcvs.2021.02.097","article-title":"Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients","volume":"163","author":"Chow","year":"2022","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.ccc.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock, A Clinical Trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"10.1016\/j.ccc.2023.06.002_bib31","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/01.CIR.102.16.2011","article-title":"Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury","volume":"102","author":"Orfanos","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13054-017-1869-9","article-title":"Angiotensin II in vasodilatory shock: lights and shadows","volume":"21","author":"Antonucci","year":"2017","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/08850666221145864","article-title":"Angiotensin II for vasodilatory hypotension in patients requiring mechanical circulatory support","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J Intensive Care Med"},{"issue":"8 Pt A","key":"10.1016\/j.ccc.2023.06.002_bib35","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1053\/j.jvca.2022.01.002","article-title":"Angiotensin II in patients with shock on mechanical circulatory support: a single-center retrospective case series","volume":"36","author":"Mohamed","year":"2022","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ccc.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajem.2023.01.050","article-title":"Efficacy and safety of angiotensin II in cardiogenic shock: a systematic review","volume":"66","author":"Bansal","year":"2023","journal-title":"Am J Emerg Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib37","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.ccc.2023.06.002_bib38","doi-asserted-by":"crossref","first-page":"e0142605","DOI":"10.1371\/journal.pone.0142605","article-title":"Non-adrenergic vasopressors in patients with or at risk for vasodilatory shock. A systematic review and meta-analysis of randomized trials","volume":"10","author":"Belletti","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ccc.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0218492321998523","article-title":"Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: a systematic review and meta-analysis","volume":"29","author":"Perdhana","year":"2021","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival","volume":"104","author":"Mehaffey","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.ccc.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1053\/j.jvca.2020.12.042","article-title":"Methylene blue for vasoplegia during extracorporeal membrane oxygenation support","volume":"35","author":"Ortoleva","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib43","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.athoracsur.2020.05.172","article-title":"Methylene blue does not improve vasoplegia after left ventricular assist device implantation","volume":"111","author":"Saha","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/j.ccc.2023.06.002_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.psym.2018.06.012","article-title":"Serotonin toxicity and urinary analgesics: a case report and systematic literature review of methylene blue-induced serotonin syndrome","volume":"59","author":"Zuschlag","year":"2018","journal-title":"Psychosomatics"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.athoracsur.2013.08.050","article-title":"The use of high dose hydroxocobalamin for vasoplegic syndrome","volume":"97","author":"Roderique","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ccc.2023.06.002_bib46","doi-asserted-by":"crossref","DOI":"10.1177\/2050312120935466","article-title":"Vasoplegia after cardiopulmonary bypass: a narrative review of pathophysiology and emerging targeted therapies","volume":"8","author":"Barnes","year":"2020","journal-title":"SAGE Open Med"},{"issue":"4","key":"10.1016\/j.ccc.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.jvca.2018.08.017","article-title":"Hydroxocobalamin for the Treatment of vasoplegia: a review of current literature and considerations for use","volume":"33","author":"Shapeton","year":"2019","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"8 Pt B","key":"10.1016\/j.ccc.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1053\/j.jvca.2022.01.021","article-title":"Predicting the response of hydroxocobalamin in postoperative vasoplegia in recipients of cardiopulmonary bypass","volume":"36","author":"Vollmer","year":"2022","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1053\/j.jvca.2021.05.042","article-title":"Hydroxocobalamin or methylene blue for vasoplegic syndrome in adult cardiothoracic surgery","volume":"36","author":"Kram","year":"2022","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ccc.2023.06.002_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcrc.2021.09.024","article-title":"Effects of a single bolus of hydroxocobalamin on hemodynamics in vasodilatory shock","volume":"67","author":"Ritter","year":"2022","journal-title":"J\u00a0Crit Care"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hrtlng.2020.11.003","article-title":"Extended duration infusion of high dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery","volume":"50","author":"Seelhammer","year":"2021","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ckj\/sfx004","article-title":"High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm","volume":"10","author":"Cheungpasitporn","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ccc.2023.06.002_bib53","doi-asserted-by":"crossref","first-page":"783164","DOI":"10.3389\/fnut.2021.783164","article-title":"The pyruvate dehydrogenase complex in sepsis: metabolic regulation and targeted therapy","volume":"8","author":"Zeng","year":"2021","journal-title":"Front Nutr"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jemermed.2013.04.022","article-title":"Altered and unstable: wet beriberi, a clinical review","volume":"45","author":"Chisolm-Straker","year":"2013","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ccc.2023.06.002_bib55","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13054-015-1131-2","article-title":"Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?","volume":"19","author":"Carr","year":"2015","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/antiox6030049","article-title":"Vitamin C and microvascular dysfunction in systemic inflammation","volume":"6","author":"Tyml","year":"2017","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.ccc.2023.06.002_bib57","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","article-title":"Hydrocortisone, Vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study","volume":"151","author":"Marik","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/CCM.0000000000001572","article-title":"Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study","volume":"44","author":"Donnino","year":"2016","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccc.2023.06.002_bib59","first-page":"96","article-title":"Vitamin C for vasoplegia after cardiopulmonary bypass: a case series","volume":"11","author":"Wieruszewski","year":"2018","journal-title":"In Pract"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.jvca.2019.08.034","article-title":"A\u00a0pilot, double-blind, randomized, controlled trial of high-dose intravenous vitamin c for vasoplegia after cardiac surgery","volume":"34","author":"Yanase","year":"2020","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"6","key":"10.1016\/j.ccc.2023.06.002_bib61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.nut.2013.10.026","article-title":"Massive and long-lasting decrease in vitamin C plasma levels as a consequence of extracorporeal circulation","volume":"30","author":"Rodemeister","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.ccc.2023.06.002_bib62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13054-016-1245-1","article-title":"Thiamine as an adjunctive therapy in cardiac surgery: a randomized, double-blind, placebo-controlled, phase II trial","volume":"20","author":"Andersen","year":"2016","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib63","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1053\/j.jvca.2019.08.044","article-title":"Sustained high-dose thiamine supplementation in high-risk cardiac patients undergoing cardiopulmonary bypass: a pilot feasibility study (the APPLY trial)","volume":"34","author":"Lomivorotov","year":"2020","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"6","key":"10.1016\/j.ccc.2023.06.002_bib64","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-5223(95)70027-7","article-title":"Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans","volume":"110","author":"Hill","year":"1995","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"24","key":"10.1016\/j.ccc.2023.06.002_bib65","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1073\/pnas.87.24.10043","article-title":"Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells","volume":"87","author":"Radomski","year":"1990","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccc.2023.06.002_bib67","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"ADRENAL trial investigators and the australian\u2013New Zealand intensive care society clinical trials group. Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ccc.2023.06.002_bib68","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.ccc.2023.06.002_bib69","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib70","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1002\/ams2.563","article-title":"Hydrocortisone with fludrocortisone for septic shock: a systematic review and meta-analysis","volume":"7","author":"Yamamoto","year":"2020","journal-title":"Acute Med Surg"},{"issue":"10000","key":"10.1016\/j.ccc.2023.06.002_bib71","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"SIRS Investigators. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock","year":"2015","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.ccc.2023.06.002_bib72","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.2012.14144","article-title":"Dexamethasone for cardiac surgery (DECS) study group. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial","volume":"308","author":"Dieleman","year":"2012","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ccc.2023.06.002_bib73","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1440-1843.2011.02018.x","article-title":"Low-dose hydrocortisone treatment for patients with septic shock: a pilot study comparing 3days with 7days","volume":"16","author":"Huh","year":"2011","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib74","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13613-018-0379-5","article-title":"Predictors of response to fixed-dose vasopressin n in adult patients with septic shock","volume":"8","author":"Sacha","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ccc.2023.06.002_bib75","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/jth.14566","article-title":"Ischemic limb necrosis in septic shock: what is the role of high-dose vasopressor therapy?","volume":"11","author":"Levy","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"issue":"4","key":"10.1016\/j.ccc.2023.06.002_bib76","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cardfail.2021.11.020","article-title":"Vasoplegia following orthotopic heart transplantation: prevalence, predictors and clinical outcomes","volume":"28","author":"Batchelor","year":"2022","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.ccc.2023.06.002_bib77","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.athoracsur.2017.09.039","article-title":"Characterizing predictors and severity of vasoplegia syndrome after heart transplantation","volume":"105","author":"Chan","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"11","key":"10.1016\/j.ccc.2023.06.002_bib78","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.amjcard.2018.08.035","article-title":"Relation of vasoplegia in the absence of primary graft dysfunction to mortality following cardiac transplantation","volume":"122","author":"Raza","year":"2018","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ccc.2023.06.002_bib79","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.21037\/jtd.2020.03.53","article-title":"Vasoplegia following heart transplantation and left ventricular assist device explant is not associated with inferior outcomes","volume":"12","author":"Ali","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib80","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/icvts\/ivx081","article-title":"Vasoplegia after heart transplantation: outcomes at 1 year","volume":"25","author":"Chan","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"2","key":"10.1016\/j.ccc.2023.06.002_bib81","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.semtcvs.2016.05.011","article-title":"Vasodilatory shock after ventricular assist device placement: a bench to bedside review","volume":"28","author":"Baer","year":"2016","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ccc.2023.06.002_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12871-018-0645-y","article-title":"Vasoplegia after implantation of a continuous flow left ventricular assist device: incidence, outcomes and predictors","volume":"18","author":"de Waal","year":"2018","journal-title":"BMC Anesthesiol"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070423000416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070423000416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:31:34Z","timestamp":1760063494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070423000416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0749070423000416"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2023.06.002","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Vasoplegic Shock in the Cardiovascular Intensive Care Unit after Cardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Critical Care Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccc.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}